Medtronic (MDT) Stock Price

Medtronic Price

🇮🇪NYSE·CLOSED
79.34USD
Market closed
Today +/-
Today %

Medtronic (MDT) Stock | ISIN IE00BTN1Y115 | WKN A14M2J. The current Medtronic stock price is 79.34 USD (2026). Revenue is 36.53 B USD. Net income is 7.35 B USD. The P/E ratio is 13.93. Market capitalization is 102.34 B USD. Medtronic operates in the Health sector.

Over the last 19 years Medtronic grew revenue by 5.9% annually, reaching 33.54 B USD. Earnings per share have grown at 2.9% per year over the last 19 years. For Medtronic, the net margin of 13.9% is up versus 12% a few years ago. At today's price the dividend yield works out to roughly 3.57%. The payout ratio is around 76% of earnings. The dividend has grown at 10.7% per year over the past 19 years.

Medtronic stock price

Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Medtronic over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Medtronic stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Medtronic's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Medtronic Stock Price History
DateMedtronic Price
Access this data via the Eulerpool API
Get Free API Key

Medtronic Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2006
11.29 B USD
3.54 B USD
2.55 B USD
Jan 1, 2007
12.3 B USD
3.54 B USD
2.8 B USD
Jan 1, 2008
13.52 B USD
3.66 B USD
2.14 B USD
Jan 1, 2009
14.6 B USD
4.18 B USD
2.07 B USD
Jan 1, 2010
15.39 B USD
4.68 B USD
3.1 B USD
Jan 1, 2011
15.51 B USD
4.48 B USD
3.1 B USD
Jan 1, 2012
16.18 B USD
4.49 B USD
3.62 B USD
Jan 1, 2013
16.59 B USD
4.8 B USD
3.47 B USD
Jan 1, 2014
17.01 B USD
4.83 B USD
3.07 B USD
Jan 1, 2015
20.26 B USD
4.77 B USD
2.68 B USD
Jan 1, 2016
28.83 B USD
5.96 B USD
3.54 B USD
Jan 1, 2017
29.71 B USD
5.96 B USD
4.03 B USD
Jan 1, 2018
29.95 B USD
6.66 B USD
3.1 B USD
Jan 1, 2019
30.56 B USD
6.9 B USD
4.63 B USD
Jan 1, 2020
28.91 B USD
5.56 B USD
4.79 B USD

Medtronic Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jun 20, 2026, 2:43 PM
 
REVENUE (B USD)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (B USD)
NET INCOME (B USD)
NET INCOME GROWTH (%)
DIV. (USD)
DIV. GROWTH (%)
SHARES (B)
DOCUMENTS
2023202420252026e2027e2028e2029e2030e
31.2332.3633.5436.5338.9840.9743.1645.33
-1.453.643.628.916.715.15.355.02
65.9865.7365.3960.0456.2753.5450.8248.39
20.6121.2721.9321.9321.9321.9321.9321.93
3.763.684.667.357.928.539.2610
-25.42-2.1826.8257.577.817.738.497.98
2.752.792.830.714.795.1--
31.451.43-74.91574.656.47––
1.331.331.291.291.291.291.291.29
––––––––
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Medtronic generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Medtronic retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Medtronic's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Medtronic has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Medtronic's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Medtronic stock margins

The Medtronic margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Medtronic. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Medtronic.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2006
75.07 %
31.33 %
22.56 %
Jan 1, 2007
74.31 %
28.74 %
22.78 %
Jan 1, 2008
74.5 %
27.04 %
15.82 %
Jan 1, 2009
75.9 %
28.65 %
14.18 %
Jan 1, 2010
76.73 %
30.39 %
20.13 %
Jan 1, 2011
76.14 %
28.91 %
19.96 %
Jan 1, 2012
75.97 %
27.76 %
22.35 %
Jan 1, 2013
75.13 %
28.91 %
20.9 %
Jan 1, 2014
74.52 %
28.42 %
18.02 %
Jan 1, 2015
68.86 %
23.53 %
13.2 %
Jan 1, 2016
68.29 %
20.67 %
12.27 %
Jan 1, 2017
68.81 %
20.06 %
13.56 %
Jan 1, 2018
69.82 %
22.22 %
10.36 %
Jan 1, 2019
70.34 %
22.58 %
15.16 %
Jan 1, 2020
67.94 %
19.24 %
16.56 %

Medtronic Stock Revenue, EBIT, Earnings per Share

The Medtronic earnings per share therefore indicates how much revenue Medtronic has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2006
9.28 USD
2.91 USD
2.09 USD
Jan 1, 2007
10.58 USD
3.04 USD
2.41 USD
Jan 1, 2008
11.81 USD
3.19 USD
1.87 USD
Jan 1, 2009
12.97 USD
3.71 USD
1.84 USD
Jan 1, 2010
13.88 USD
4.22 USD
2.79 USD
Jan 1, 2011
14.33 USD
4.14 USD
2.86 USD
Jan 1, 2012
15.27 USD
4.24 USD
3.41 USD
Jan 1, 2013
16.14 USD
4.67 USD
3.37 USD
Jan 1, 2014
16.77 USD
4.77 USD
3.02 USD
Jan 1, 2015
18.27 USD
4.3 USD
2.41 USD
Jan 1, 2016
20.22 USD
4.18 USD
2.48 USD
Jan 1, 2017
21.36 USD
4.28 USD
2.9 USD
Jan 1, 2018
21.9 USD
4.87 USD
2.27 USD
Jan 1, 2019
22.5 USD
5.08 USD
3.41 USD
Jan 1, 2020
21.4 USD
4.12 USD
3.54 USD

Medtronic business model & stock analysis

Medtronic PLC is a globally leading medical technology company headquartered in Dublin, Ireland. The company was founded in 1949 by Earl Bakken and Palmer Hermundslie and has since developed a comprehensive portfolio of products in the field of medical devices and equipment. Medtronic's business model is focused on meeting the demand for innovative medical technology to improve the quality of life for patients and treat or alleviate diseases and disorders. The company strives to constantly invest in research and development to bring new and improved products to the market. Medtronic offers an extensive range of products that can be used in the fields of cardiology, neuromodulation, spinal surgery, diabetes, hearing aids, surgery, ophthalmology, infection prevention, percutaneous intervention procedures, and more. One of the most well-known product series is the pacemaker, which has been manufactured by Medtronic in a variety of models since 1957. In the field of neuromodulation, Medtronic is a leader in the development of implants that can treat various disorders of the nervous system. This includes deep brain stimulation (DBS) for Parkinson's disease, as well as spinal cord stimulation procedures for chronic pain and neurostimulation procedures for bladder, bowel, and gastrointestinal disorders.. In the field of spinal medicine, Medtronic offers a variety of devices that contribute to the stabilization of the spine and can be implemented through minimally invasive procedures. These include products such as plate systems, cages, spinal stabilizations, chamber drains, medication pumps, and more. In the field of diabetes, Medtronic focuses on the development of insulin pump systems that allow for more precise administration of insulin. The system also includes a sensor that continuously monitors blood sugar levels and can trigger insulin delivery as needed. Medtronic is also known for its efforts in infection prevention, offering products such as antimicrobial catheters, wound care, and hospital hygiene solutions. In addition to its products, the company is also involved in medical education and consulting. As part of these efforts, Medtronic develops training and education programs for physicians and healthcare personnel to enhance techniques and the use of devices and systems. Over the years, Medtronic has expanded its product offering through mergers and acquisitions. Currently, the company employs over 86,000 people in locations across more than 160 countries worldwide. Overall, Medtronic aims to drive innovation in medical technology and enable better healthcare for patients worldwide through its products and services.

Medtronic SWOT Analysis

Strengths

Medtronic PLC holds a strong position in the medical technology industry, exhibiting several notable strengths:

  • Extensive product portfolio, with a wide range of medical devices and therapies.
  • Established global presence, operating in various countries worldwide.
  • Excellent research and development capabilities, leading to innovative solutions.
  • Strong brand reputation, recognized for quality and reliability.
  • Strong financial performance and stability, allowing for investment in future growth.

Despite its strengths, Medtronic PLC faces certain weaknesses that can hinder its performance:

  • Dependency on regulatory approvals, as the company's products are subject to government regulations.
  • Vulnerability to product recalls or safety concerns due to the nature of healthcare devices.
  • Relatively high prices of certain products, limiting affordability for some customers.

Medtronic PLC has various opportunities to leverage and expand its business:

  • Growing demand for advanced medical devices in emerging markets.
  • Increasing global healthcare expenditure, providing potential for revenue growth.
  • Innovation in healthcare technology, allowing for the development of new products.
  • Potential mergers and acquisitions to expand market share and product offerings.

Medtronic PLC faces several threats that may impact its performance and market position:

  • Intense competition from other medical technology companies.
  • Changes in government regulations and healthcare policies affecting market dynamics.
  • Slowdown in global economic conditions leading to reduced healthcare spending.
  • Rapid technological advancements and potential disruption by new entrants.

Weaknesses

Despite its strengths, Medtronic PLC faces certain weaknesses that can hinder its performance:

  • Dependency on regulatory approvals, as the company's products are subject to government regulations.
  • Vulnerability to product recalls or safety concerns due to the nature of healthcare devices.
  • Relatively high prices of certain products, limiting affordability for some customers.

Medtronic PLC has various opportunities to leverage and expand its business:

  • Growing demand for advanced medical devices in emerging markets.
  • Increasing global healthcare expenditure, providing potential for revenue growth.
  • Innovation in healthcare technology, allowing for the development of new products.
  • Potential mergers and acquisitions to expand market share and product offerings.

Medtronic PLC faces several threats that may impact its performance and market position:

  • Intense competition from other medical technology companies.
  • Changes in government regulations and healthcare policies affecting market dynamics.
  • Slowdown in global economic conditions leading to reduced healthcare spending.
  • Rapid technological advancements and potential disruption by new entrants.

Opportunities

Medtronic PLC has various opportunities to leverage and expand its business:

  • Growing demand for advanced medical devices in emerging markets.
  • Increasing global healthcare expenditure, providing potential for revenue growth.
  • Innovation in healthcare technology, allowing for the development of new products.
  • Potential mergers and acquisitions to expand market share and product offerings.

Medtronic PLC faces several threats that may impact its performance and market position:

  • Intense competition from other medical technology companies.
  • Changes in government regulations and healthcare policies affecting market dynamics.
  • Slowdown in global economic conditions leading to reduced healthcare spending.
  • Rapid technological advancements and potential disruption by new entrants.

Threats

Medtronic PLC faces several threats that may impact its performance and market position:

  • Intense competition from other medical technology companies.
  • Changes in government regulations and healthcare policies affecting market dynamics.
  • Slowdown in global economic conditions leading to reduced healthcare spending.
  • Rapid technological advancements and potential disruption by new entrants.

Medtronic Eulerpool Fair Value

Medtronic historical P/E ratio, EBIT multiple, and P/S ratio

Medtronic annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Medtronic shares outstanding

The number of shares was Medtronic in 2025 — This indicates how many shares 1.29 B is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2006
1.22 B base_Shares
Jan 1, 2007
1.16 B base_Shares
Jan 1, 2008
1.14 B base_Shares
Jan 1, 2009
1.13 B base_Shares
Jan 1, 2010
1.11 B base_Shares
Jan 1, 2011
1.08 B base_Shares
Jan 1, 2012
1.06 B base_Shares
Jan 1, 2013
1.03 B base_Shares
Jan 1, 2014
1.01 B base_Shares
Jan 1, 2015
1.11 B base_Shares
Jan 1, 2016
1.43 B base_Shares
Jan 1, 2017
1.39 B base_Shares
Jan 1, 2018
1.37 B base_Shares
Jan 1, 2019
1.36 B base_Shares
Jan 1, 2020
1.35 B base_Shares

Medtronic Dividend History

37 years of dividend payments · 12 consecutive increases

YearAnnual DividendYoY ChangePayments
20260.71USDYTD—1×
Mar 27, 20260.71USD 0.0%1/1
20252.83USD↑ 1.4%4×
Mar 28, 20250.7USD 0.0%1/4
Jun 27, 20250.71USD↑ 1.4%2/4
Sep 26, 20250.71USD 0.0%3/4
Dec 26, 20250.71USD 0.0%4/4
20242.79USD↑ 1.5%4×
20232.75USD↑ 3.0%4×
20222.67USD↑ 8.1%4×
20212.47USD↑ 8.3%4×
20202.28USD↑ 7.5%4×
20192.12USD↑ 8.2%4×
20181.96USD↑ 8.3%4×
20171.81USD↑ 8.4%4×

Medtronic dividend history and estimates

In 2025, Medtronic paid a dividend amounting to 2.83 USD. Dividend means that Medtronic distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2006
0.41 USD
0 USD
Jan 1, 2007
0.47 USD
0 USD
Jan 1, 2008
0.81 USD
0 USD
Jan 1, 2009
0.6 USD
0 USD
Jan 1, 2010
0.86 USD
0 USD
Jan 1, 2011
0.94 USD
0 USD
Jan 1, 2012
1.27 USD
0 USD
Jan 1, 2013
1.1 USD
0 USD
Jan 1, 2014
1.19 USD
0 USD
Jan 1, 2015
1.44 USD
0 USD
Jan 1, 2016
1.67 USD
0 USD
Jan 1, 2017
1.81 USD
0 USD
Jan 1, 2018
1.96 USD
0 USD
Jan 1, 2019
2.12 USD
0 USD
Jan 1, 2020
2.28 USD
0 USD

Medtronic dividend payout ratio

In 2025, Medtronic had a payout ratio of 76.03%. The payout ratio indicates the percentage of the company's profits that Medtronic distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2006
19.74 %
Jan 1, 2007
19.5 %
Jan 1, 2008
43.45 %
Jan 1, 2009
32.47 %
Jan 1, 2010
30.94 %
Jan 1, 2011
32.69 %
Jan 1, 2012
37.1 %
Jan 1, 2013
32.64 %
Jan 1, 2014
39.57 %
Jan 1, 2015
59.96 %
Jan 1, 2016
67.34 %
Jan 1, 2017
62.63 %
Jan 1, 2018
86.73 %
Jan 1, 2019
61.99 %
Jan 1, 2020
64.41 %
Price targets and forecasts for Medtronic are not yet available.

Medtronic Earnings Calls

2024
2023

Medtronic Earnings Estimates

Medtronic Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
6/3/20261.56USD9.73 BUSD2026 Q4
2/17/20261.35USD8.99 BUSD2026 Q3
11/18/20251.33USD8.95 BUSD2026 Q2
8/19/20251.24USD8.46 BUSD2026 Q1
11/19/20241.26USD8.36 BUSD2025 Q2
5/25/20231.72USD8.61 BUSD2023 Q4
2/21/20231.42USD8.08 BUSD2023 Q3
11/22/20221.29USD7.82 BUSD2023 Q2
8/23/20221.13USD7.33 BUSD2023 Q1
5/26/20221.58USD8.55 BUSD2022 Q4
...

EESG©

Eulerpool ESG Scorecard© for the Medtronic stock

70/100
74
Environment
85
Social
52
Governance
E

Environment

20
Scope 1 - Direct Emissions99,000
Scope 2 - Indirect emissions from purchased energy118,000
Scope 3 - Indirect emissions within the value chain3,213,000
Total CO₂ emissions217,000
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides—
Palm Oil
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees51
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Medtronic Executives and Management Board

GM

Mr. Geoffrey Martha

(55)

Executive Chairman of the Board, Chief Executive Officer · since 2011

Compensation21.24 M USD
IF

Mr. Ivan Fong

(63)

Executive Vice President, General Counsel, Corporate Secretary

Compensation11.72 M USD
BW

Mr. Brett Wall

(60)

Executive Vice President, President - Neuroscience Portfolio

Compensation8.12 M USD
GS

Mr. Gregory Smith

(61)

Executive Vice President - Enterprise Operations

Compensation8.08 M USD
TP

Mr. Thierry Pieton

(55)

Chief Financial Officer, Executive Vice President

Compensation5.21 M USD

Medtronic Supply Chain

Frequently asked questions about Medtronic

The business model of Medtronic PLC primarily focuses on the development, manufacturing, and distribution of medical technology devices and solutions. Medtronic specializes in the fields of cardiac and vascular therapies, minimally invasive therapies, restorative therapies, and diabetes management. The company aims to improve patient outcomes by providing innovative and high-quality products to healthcare professionals worldwide. Medtronic's business model revolves around collaborating with healthcare providers, patients, and other stakeholders to create innovative solutions that address unmet medical needs. Through strategic partnerships and continuous research and development, Medtronic strives to enhance patient care and improve the overall healthcare landscape.

All fundamentals and in-depth analysis of Medtronic

Our stock analysis for Medtronic Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medtronic Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Medtronic Stock
Medtronic Revenue→
Medtronic Stock
Medtronic Net Income→
Medtronic Stock
Medtronic P/E→
Medtronic Stock
Medtronic P/S→
Medtronic Stock
Medtronic EBIT→
Medtronic Stock
Medtronic Dividend→
Medtronic Stock
Medtronic Directors Dealings→
Medtronic Stock
Medtronic Stocks→
Medtronic Stock
Medtronic Market capitalization→
Medtronic Stock
Medtronic Debt→
Medtronic Stock
Medtronic Liabilities→
Medtronic Stock
Medtronic Equity→
Medtronic Stock
Medtronic AAQS→
Medtronic Stock
Medtronic Employees→
Medtronic Stock
Medtronic ROE→
Medtronic Stock
Medtronic ROA→
Medtronic Stock
Medtronic ROCE→